Total Payments
$1.7M
2024 Payments
$199,722
Companies
54
Transactions
5,239
Medicare Patients
4,044
Medicare Billing
$1.0M
Payment Breakdown by Category
Other$1.5M (86.5%)
Travel$101,973 (5.9%)
Food & Beverage$89,045 (5.2%)
Consulting$40,291 (2.3%)
Education$495.10 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.5M | 610 | 85.7% |
| Travel and Lodging | $101,973 | 711 | 5.9% |
| Food and Beverage | $89,045 | 3,872 | 5.2% |
| Consulting Fee | $40,291 | 15 | 2.3% |
| Compensation for serving as faculty or as a speaker for a medical education program | $12,416 | 6 | 0.7% |
| Honoraria | $2,013 | 2 | 0.1% |
| Education | $495.10 | 23 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $504,428 | 831 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $332,782 | 515 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $233,928 | 507 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $187,079 | 661 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $140,234 | 513 | $0 (2022) |
| BioXcel Therapeutics, Inc. | $56,270 | 122 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $45,843 | 185 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $40,927 | 228 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $31,961 | 96 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $25,100 | 103 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $199,722 | 811 | Alkermes, Inc. ($58,526) |
| 2023 | $352,022 | 933 | Alkermes, Inc. ($111,504) |
| 2022 | $205,013 | 728 | Neurocrine BioSciences, Inc. ($75,678) |
| 2021 | $185,186 | 743 | Neurocrine Biosciences, Inc. ($64,962) |
| 2020 | $104,807 | 446 | Alkermes, Inc. ($52,677) |
| 2019 | $299,320 | 610 | Avanir Pharmaceuticals, Inc. ($111,211) |
| 2018 | $207,173 | 498 | Sunovion Pharmaceuticals Inc. ($66,114) |
| 2017 | $163,642 | 470 | Sunovion Pharmaceuticals Inc. ($64,361) |
All Payment Transactions
5,239 individual payment records from CMS Open Payments — Page 1 of 210
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,405.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/30/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,405.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/24/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: ADHD | ||||||
| 12/24/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $1.08 | General |
| Category: ADHD | ||||||
| 12/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: Neuropsychiatry | ||||||
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $102.00 | General |
| 12/19/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: CNS | ||||||
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $5.21 | General |
| Category: ADHD | ||||||
| 12/19/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $1.25 | General |
| Category: CNS | ||||||
| 12/18/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/18/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $167.50 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/18/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $119.63 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $11.30 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $4.05 | General |
| Category: CNS | ||||||
| 12/17/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/17/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $110.85 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/17/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $16.08 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,405.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.41 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $21.44 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Central Nervous System | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $5.93 | General |
| Category: Psychiatry/Psychology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 558 | 1,857 | $230,625 | $119,798 |
| 2022 | 13 | 865 | 3,409 | $402,365 | $199,991 |
| 2021 | 16 | 1,369 | 5,176 | $611,816 | $327,487 |
| 2020 | 15 | 1,252 | 6,056 | $631,505 | $363,702 |
Total Patients
4,044
Total Services
16,498
Medicare Billing
$1.0M
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 121 | 568 | $83,299 | $51,262 | 61.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 129 | 521 | $52,984 | $30,688 | 57.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 128 | 480 | $59,944 | $19,910 | 33.2% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 31 | 100 | $8,962 | $5,017 | 56.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 52 | 52 | $9,451 | $4,945 | 52.3% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 32 | 32 | $5,440 | $3,177 | 58.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 25 | 27 | $2,725 | $1,690 | 62.0% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 20 | 34 | $4,250 | $1,569 | 36.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 20 | 43 | $3,569 | $1,542 | 43.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 232 | 1,633 | $163,300 | $89,919 | 55.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 145 | 1,025 | $128,125 | $53,483 | 41.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 102 | 107 | $28,890 | $15,839 | 54.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 154 | 184 | $18,400 | $10,239 | 55.6% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 54 | 125 | $15,625 | $8,844 | 56.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 60 | $8,310 | $4,536 | 54.6% |
| 90870 | Therapy using electrical currents | Facility | 2022 | 12 | 55 | $12,375 | $4,496 | 36.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 47 | 50 | $7,170 | $3,831 | 53.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 41 | 90 | $7,210 | $2,629 | 36.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 21 | $3,780 | $2,212 | 58.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 14 | 14 | $3,150 | $1,707 | 54.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 11 | 23 | $2,070 | $1,225 | 59.2% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 21 | 22 | $3,960 | $1,032 | 26.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 307 | 2,643 | $263,906 | $148,779 | 56.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 162 | 1,166 | $141,620 | $73,156 | 51.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 197 | 218 | $58,860 | $32,775 | 55.7% |
About Dr. Vadim Baram, MD
Dr. Vadim Baram, MD is a Geriatric Psychiatry healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124007380.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vadim Baram, MD has received a total of $1.7M in payments from pharmaceutical and medical device companies, with $199,722 received in 2024. These payments were reported across 5,239 transactions from 54 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.5M).
As a Medicare-enrolled provider, Baram has provided services to 4,044 Medicare beneficiaries, totaling 16,498 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Psychiatry
- Other Specialties Psychiatry
- Location Saint Louis, MO
- Active Since 01/15/2006
- Last Updated 03/07/2023
- Taxonomy Code 2084P0805X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124007380
Products in Payments
- INGREZZA (Drug) $332,764
- ARISTADA (Drug) $246,276
- NUEDEXTA (Drug) $217,442
- LYBALVI (Drug) $158,033
- LATUDA (Drug) $138,711
- AUSTEDO (Drug) $109,484
- Aristada 441 mg (Drug) $91,433
- IGALMI (Drug) $56,270
- NUPLAZID (Drug) $45,843
- UZEDY (Drug) $44,972
- FANAPT (Drug) $38,985
- Trintellix (Drug) $35,590
- Austedo XR (Drug) $31,007
- ABILIFY MAINTENA (Drug) $27,663
- CAPLYTA (Drug) $25,265
- Nuedexta (Drug) $16,486
- Xelstrym (Drug) $14,889
- VRAYLAR (Drug) $14,257
- COBENFY (Drug) $11,813
- Auvelity (Drug) $10,392
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Geriatric Psychiatry Doctors in Saint Louis
George Grossberg, Md, MD
Geriatric Psychiatry — Payments: $417,080
Geriatric Psychiatry $417,080
Dr. Eric Lenze, Md, MD
Geriatric Psychiatry — Payments: $74,044
Geriatric Psychiatry $74,044
Sameer Arain, Md, MD
Geriatric Psychiatry — Payments: $8,394
Geriatric Psychiatry $8,394
Dr. Nezar El-Ruwie, M.d, M.D
Geriatric Psychiatry — Payments: $372.93
Geriatric Psychiatry $372.93
William Irvin, Md, MD
Geriatric Psychiatry — Payments: $259.00
Geriatric Psychiatry $259.00
Daniel Loiterstein, M.d, M.D
Geriatric Psychiatry — Payments: $99.89
Geriatric Psychiatry $99.89